Danish Research Center For Skin Cancer

What Danish Research Center For Skin Cancer does

The Danish Research Center for Skin Cancer (Videncenter for Hudkræft) is a public-private research consortium established in 2020 and headquartered at Bispebjerg Hospital in Copenhagen, Denmark. It is jointly operated by three Danish healthcare institutions — Bispebjerg Hospital, Aalborg University Hospital, and Privathospitalet Mølholm — and operates as Denmark's national research platform dedicated to skin cancer prevention, diagnosis, and treatment. The center brings together approximately 40 affiliated researchers across multiple disciplines, including Professor Merete Hædersdal's 19-person team focused on energy-based devices and laser-assisted drug delivery, and Susanne Krüger Kjær's 21-person group studying HPV, vaccination, and cancer prevention.

The center's technology portfolio spans medical imaging and optical diagnostics (LC-OCT for digital skin biopsies, Dynamic OCT for vascular analysis of actinic keratosis), AI-based diagnostic tools (the SCAI smartphone application with 92% sensitivity and 95.5% specificity in detecting simulated skin changes), laser-assisted drug delivery protocols for enhanced pharmaceutical penetration, and the SunSaver wearable UV dosimeter for continuous exposure monitoring. It has produced over 300 scientific publications and contributes to national clinical guidelines. Strategic collaborations include Massachusetts General Hospital/Harvard Medical School, the Danish Cancer Society Research Center, and the Novo Nordisk Foundation (which funds the ICARUS interdisciplinary UV research project extending into Greece).

The center is not a commercial product or services company. It is funded through government research grants, institutional partnerships, and private foundation support, and operates under a professional services / public research funding model. Revenue from commercial product sales is not generated. Clinical trial participants are recruited through the center's website and direct outreach (e.g., women aged 50+ with low heat resilience for ICARUS), and findings are disseminated via publications, clinical guidelines, partner hospital clinics, the QuickPubMed skin cancer literature search engine, and international conferences such as IMCAS World Congress.

Name

Danish Research Center For Skin Cancer

Legal name

Videncenter for Hudkræft

Website

https://vfhk.org

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

The Danish Research Center for Skin Cancer (Videncenter for Hudkræft) is a public-private Danish research consortium advancing skin cancer prevention, diagnosis, and treatment through partnerships with three Danish hospitals, AI-powered diagnostic tools, and clinical research.

Ownership category

akta.pro rank

Product category

Dermatology Research Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Mohs Surgery & Skin Cancer (Dermatologic Oncology) (HLAKACAD)

Keywords

• Skin cancer research
• Dermatology studies
• Clinical trials dermatology
• Optical skin imaging
• Skin cancer prevention

Headquarters

HQ city

Copenhagen

HQ country

Denmark

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Public Research Funding: The center operates as a public-private research consortium funded through government research grants and institutional partnerships. It is not a commercial entity generating product revenue.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Danish Research Center For Skin Cancer (Videncenter for Hudkræft) is a public-private research consortium that conducts clinical and translational research on the prevention, diagnosis, and treatment of skin cancer. It operates research projects and clinical trials across three partner hospitals, develops clinical guidelines for Danish dermatologists, and produces scientific publications. Its offerings include research initiatives (e.g., VAXAK, ICARUS), clinical trial participation, educational content for patients and physicians, and specialized research tools such as the QuickPubMed search engine and the SunSaver UV dosimeter.

Product overview

Danish Research Center For Skin Cancer (Videncenter for Hudkræft) is a public-private research collaboration between Privathospitalet Mølholm, Aalborg Universitetshospital, and Bispebjerg Hospital. The center operates primarily as a research institution rather than a product company, conducting clinical research on skin cancer prevention, diagnosis, and treatment. Their offerings include research projects, clinical trial participation opportunities, scientific publications, and educational resources for patients and healthcare professionals. Key research tools include the QuickPubMed search engine for skin cancer literature and the SunSaver UV dosimeter device used in research studies.

Differentiator

Problem solved

Functional benefit

Products and services

• QuickPubMed for Skin Cancer A specialized online search engine that enables physicians and researchers to find, sort, and summarize scientific literature about skin cancer from the PubMed database, enhanced with AI-powered summarization capabilities. Built for dermatologists, researchers, and clinicians.
• SunSaver UV Dosimeter A small wearable UV measurement device developed for skin cancer research that continuously measures UV radiation exposure and remotely transmits data for up to six months on a single charge. Used in studies such as the ICARUS project.
• vfhk.org Information Portal Educational website providing information about skin cancer prevention, diagnosis, treatment, and research; targeted at patients, at-risk individuals, physicians, and researchers. Includes clinical guidelines, news updates, and clinical trial recruitment information.
• Clinical Trial Research Programs Clinical research studies and trials investigating skin cancer prevention, diagnosis, and treatment, including the VAXAK HPV vaccination trial for actinic keratosis and the ICARUS UV radiation exposure project. Recruitment is conducted through the center's website and direct outreach to Danish participants.

Quantifiable outcome

• Sequential 5-FU and daylight PDT achieved 87% AK clearance vs 74% for PDT alone (p<0.0001)
• +4 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered core.

• Bispebjerg Hospital (Copenhagen University Hospital)coreStrategic or Co-development PartnerBispebjerg Hospital is the primary host institution for the Danish Research Center for Skin Cancer. The hospital's Dermatological Department serves as the center's secretariat location and main research base. Professor Merete Hædersdal leads research at this location alongside her team of 19 researchers. The partnership enables clinical trials and translational research in dermatology.
• Aalborg University HospitalcoreStrategic or Co-development PartnerAalborg University Hospital hosts the Department of Dermatology as part of the public-private research consortium. Professor Peter Bjerring leads development of optical diagnostic methods for skin diseases at this site. PhD researchers including Aheen Faisal conduct research at this hospital in collaboration with the center.
• Private Hospital Mølholm (Privathospitalet Mølholm)coreStrategic or Co-development PartnerPrivate Hospital Mølholm participates as a private partner in the public-private research consortium. Flemming Andersen serves as Head of Department of Dermatology at Mølholm. The partnership brings private sector clinical capacity to the research collaboration.
• Massachusetts General Hospital, Harvard Medical SchoolcoreStrategic or Co-development PartnerProfessor Merete Hædersdal has been affiliated with Massachusetts General Hospital and Harvard Medical School since 2009 as a visiting scientist and research staff at the Wellman Center for Photomedicine. This collaboration has pioneered laser-assisted drug delivery treatment concepts now used globally in clinical practice.
• The Danish Cancer Society Research CentercoreStrategic or Co-development PartnerSusanne Krüger Kjær's research group, affiliated with the Danish Cancer Society Research Center's Virus, Lifestyle and Genes Unit, collaborates on skin cancer research including HPV and skin cancer in organ transplant patients. Susanne Krüger Kjær was appointed visiting professor at Johns Hopkins Hospital, Baltimore, USA in 2019, extending the center's international research network.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Market position

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/danish-research-center-for-skin-cancer
• Instagraminstagram.com/videncenterforhudkraeft

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Danish Research Center For Skin Cancer